Explore more publications!
Alabama STEM News
Submit Press Release

Alabama STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alabama STEM News.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 23, 2025

Kiniksa Pharmaceuticals to Report Third Quarter 2025 Financial Results on October 28, 2025
October 23, 2025

Kiniksa Pharmaceuticals to Report Third Quarter 2025 Financial Results on October 28, 2025

Indeterminate GlobeNewswire
Galapagos presenteert in vitro-gegevens tijdens ACR Convergence 2025 die wijzen op differentiatie van GLPG3667 ten opzichte van andere TYK2-remmers
October 23, 2025

Galapagos presenteert in vitro-gegevens tijdens ACR Convergence 2025 die wijzen op differentiatie van GLPG3667 ten opzichte van andere TYK2-remmers

Indeterminate GlobeNewswire
Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules
October 23, 2025

Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules

Indeterminate GlobeNewswire
Fall for Science: The Tech Interactive Unveils New Exhibits, Laser Shows, and Spooky STEAM Fun
October 23, 2025

Fall for Science: The Tech Interactive Unveils New Exhibits, Laser Shows, and Spooky STEAM Fun

Indeterminate GlobeNewswire
KZRex Exits U.S. Retail Market to Target Korea’s Crypto Elite in Bold Strategic Pivot
October 23, 2025

KZRex Exits U.S. Retail Market to Target Korea’s Crypto Elite in Bold Strategic Pivot

Indeterminate GlobeNewswire
Capital Links Investigates: Expert Legal Review of LuxUrban’s New York Tax Liability and OTA Compliance
October 23, 2025

Capital Links Investigates: Expert Legal Review of LuxUrban’s New York Tax Liability and OTA Compliance

Indeterminate GlobeNewswire
FastBots.ai Reaches 73,000 Users as Small Businesses Turn to AI for Customer Service
October 23, 2025

FastBots.ai Reaches 73,000 Users as Small Businesses Turn to AI for Customer Service

Indeterminate GlobeNewswire
Neue Untersuchung von Benevity Impact Labs deckt Vertrauenslücke unter globalen Geldgebern auf
October 23, 2025

Neue Untersuchung von Benevity Impact Labs deckt Vertrauenslücke unter globalen Geldgebern auf

Indeterminate GlobeNewswire
Une nouvelle étude de Benevity Impact Labs révèle un manque de confiance chez les subventionnaires internationaux
October 23, 2025

Une nouvelle étude de Benevity Impact Labs révèle un manque de confiance chez les subventionnaires internationaux

Indeterminate GlobeNewswire
EdgeAI Wins Technology Frontier Award at 2025 Bincheng International Innovation & Entrepreneurship Competition
October 23, 2025

EdgeAI Wins Technology Frontier Award at 2025 Bincheng International Innovation & Entrepreneurship Competition

Indeterminate GlobeNewswire
Switching from Lead-Acid to Lithium Is Easier Than You Think. LiTime's One-Stop Upgrade Solutions Empower RV, Marine, and Other Users to Go Lithium with Ease
October 23, 2025

Switching from Lead-Acid to Lithium Is Easier Than You Think. LiTime's One-Stop Upgrade Solutions Empower RV, Marine, and Other Users to Go Lithium with Ease

Indeterminate GlobeNewswire
Zymeworks Presents Initial Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺ at AACR-NCI-EORTC Conference
October 23, 2025

Zymeworks Presents Initial Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺ at AACR-NCI-EORTC Conference

Indeterminate GlobeNewswire
ALX Oncology Announces Preclinical Data and Phase 1 Trial-in-Progress Presentations of ALX2004, a Novel EGFR-Targeted ADC, at 2025 AACR-NCI-EORTC Conference
October 23, 2025

ALX Oncology Announces Preclinical Data and Phase 1 Trial-in-Progress Presentations of ALX2004, a Novel EGFR-Targeted ADC, at 2025 AACR-NCI-EORTC Conference

Indeterminate GlobeNewswire
Sword Group: Acquisition of Full On Net, strengthening its expertise in data science and digital platforms
October 23, 2025

Sword Group: Acquisition of Full On Net, strengthening its expertise in data science and digital platforms

Indeterminate GlobeNewswire
Sword Group : Acquisition de Full On Net, renforçant ainsi son expertise en data science et plateformes digitales
October 23, 2025

Sword Group : Acquisition de Full On Net, renforçant ainsi son expertise en data science et plateformes digitales

Indeterminate GlobeNewswire
Sword Group : Résultats du 3ème trimestre 2025
October 23, 2025

Sword Group : Résultats du 3ème trimestre 2025

Indeterminate GlobeNewswire
Sword Group: Q3 2025 Results
October 23, 2025

Sword Group: Q3 2025 Results

Indeterminate GlobeNewswire
Guerbet : Revenue at September 30, 2025. Return to growth in Q3 2025. Confirmation of all financial targets for 2025.
October 23, 2025

Guerbet : Revenue at September 30, 2025. Return to growth in Q3 2025. Confirmation of all financial targets for 2025.

Indeterminate GlobeNewswire
Guerbet : Chiffre d’affaires au 30 septembre 2025. Retour de la croissance au 3ème trimestre 2025. Confirmation de l’ensemble des objectifs financiers 2025.
October 23, 2025

Guerbet : Chiffre d’affaires au 30 septembre 2025. Retour de la croissance au 3ème trimestre 2025. Confirmation de l’ensemble des objectifs financiers 2025.

Indeterminate GlobeNewswire
Cegedim: like-for-like revenue growth of 2.1% over 9 months is on target
October 23, 2025

Cegedim: like-for-like revenue growth of 2.1% over 9 months is on target

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions